Skip to main content
Clinical Trials/NCT04715477
NCT04715477
Unknown
Not Applicable

Intensive Care Anxiety in SARS-CoV-2 (COVID 19) Patients

Derince Training and Research Hospital1 site in 1 country100 target enrollmentJanuary 17, 2021
ConditionsAnxiety

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
Derince Training and Research Hospital
Enrollment
100
Locations
1
Primary Endpoint
intensive care Anxiety
Last Updated
5 years ago

Overview

Brief Summary

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Registry
clinicaltrials.gov
Start Date
January 17, 2021
End Date
April 15, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Derince Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

İLKE KÜPELİ

assoc. prof.

Derince Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Above 18 years old
  • COVID PCR +,
  • admitted to intensive care,
  • conscious, cooperative patients

Exclusion Criteria

  • Having hearing and speaking problems,
  • Can't speak Turkish or English,
  • who do not have the cognitive level to understand and answer the questions,
  • Communication problems such as dementia and Alzheimer's,
  • patients receiving sedation

Outcomes

Primary Outcomes

intensive care Anxiety

Time Frame: 3 month

Hospital Anxiety Depression scale

Study Sites (1)

Loading locations...

Similar Trials